Published on: Monday, February 01, 2021
By: Bernama
Text Size:
KUALA TERENGGANU: Malaysia is expected to receive the first batch of Pfizer-BioNTech coronavirus vaccine on Feb 26, said Health director-general Tan Sri Dr Noor Hisham Abdullah.
He said that once arrived, the vaccine will be distributed in stages to the states within a week or two.
Dr Noor Hisham said this after participating in the COVID-19 Emergency Management Technical Committee meeting at the Menteri Besar Office at Wisma Darul Iman, here, today.
ADVERTISEMENT
Also present was Menteri Besar Datuk Seri Dr Ahmad Samsuri Mokhtar.
Malaysia was previously reported to have purchased 12.8 million doses of Pfizer-BioNTech coronavirus vaccine and has subsequently committed to purchase an additional 12.2 million doses of the same vaccine.
KUALA TERENGGANU (Feb 1): Malaysia is expected to receive the first batch of the Pfizer-BioNTech coronavirus vaccine on Feb 26, said health director-general Tan Sri Dr Noor Hisham Abdullah.
He said that once arrived, the vaccine will be distributed in stages to the states within a week or two.
Noor Hisham said this after participating in the Covid-19 Emergency Management Technical Committee meeting at the Menteri Besar Office at Wisma Darul Iman here today.
Also present was Terengganu Menteri Besar Datuk Seri Dr Ahmad Samsuri Mokhtar.
Malaysia was previously reported to have purchased 12.8 million doses of the Pfizer-BioNTech coronavirus vaccine and has subsequently committed to purchase an additional 12.2 million doses of the same vaccine.
Give CKD patients priority in vaccination programme
February 1, 2021
KUALA LUMPUR – The government has been urged to give priority to patients with Chronic Kidney Disease (CKD) in its COVID-19 vaccination programme.
The call was jointly made by National Kidney Foundation chairman Datuk Dr Zaki Morad, Malaysian Society of Nephrology president Prof Dr Abdul Halim Abdul Gafor and Malaysian Society of Transplantation president Dr Rosnawati Yahya
Advertisement
They said this would reduce overcrowding in the Ministry of Health’s haemodialysis (HD) centres and help return some normalcy to HD centres run by private and non-governmental organisations.
They said priority should be given to groups such as patients on haemodialysis and peritoneal dialysis, patients with functioning kidney transplants and patients with CKD stage 3-4 (pre-dialysis).